Enzymes linked with immune cell activity could hold the key to better understanding of inflammation.
Findings show promise for developing potential new anti-inflammatory drugs and treatments for autoimmune diseases.
By Adrianna MacPherson University of Alberta, Canada.
Chris Cairo and his research team found that a group of enzymes called neuraminidases could offer clues to understanding inflammation and eventually finding new ways of treating it.
The findings show promise for developing potential inflammatory therapeutics, and could be useful in treating diseases, explains Cairo, a professor in the Department of Chemistry. For example, in an autoimmune disorder where too many immune cells are being recruited to a particular area, an enzyme with a subtly anti-inflammatory effect may help turn down the intensity of that immune response while not completely eradicating the person’s immune system.
No comments:
Post a Comment